fda news - Search News

US FDA pauses Novavax's trial of combo flu-COVID shot

US FDA pauses Novavax's trial of combo flu-COVID shot on safety concerns

The U.S. Food and Drug Administration has placed a hold on trials of Novavax's COVID and influenza combination vaccine, as well as standalone flu shot due to safety concerns, the company said on Wednesday.

CNBC on MSN · 9h

Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge

Novavax said the Food and Drug Administration has put a hold on its application for a combination shot targeting Covid and influenza and a stand-alone flu vaccine, sending shares of the company down sharply.

The Wall Street Journal on MSN · 9h

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines

Novavax said federal regulators put a clinical hold on its application for a combination Covid-19 and influenza vaccine and standalone flu inoculation, sending shares down sharply.

FDA, Novocure and lung cancer

FierceBiotech · 9h

Novocure nets FDA approval for Tumor Treating Fields in metastatic lung cancer

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small cell lung cancer—which the company described as the first tre | Novocure described its Tumor Treating Fields therapy as the first of its kind for the aggressive cancer,

MarketWatch · 1d

Novocure Shares Rise After FDA Approves Optune Lua Cancer Treatment

Shares of Novocure were trading higher in Tuesday's late session after the company said that the Food and Drug Administration had approved Optune Lua, its wearable treatment for certain types of lung cancer.

Investing.com on MSN · 12h

Novocure shares soar 33% as FDA approves lung cancer treatment

Novocure Ltd (NASDAQ:NVCR) shares soared sharply after the announcement that the FDA had approved Optune Lua, a wearable device designed to treat certain types of lung cancer. The stock surged more than 33% in premarket

FDA to Reconsider Removal of Lilly's Obesity Drug

Fox Business on MSN · 13h

Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

The Motley Fool on MSN · 15h

Should Eli Lilly Investors Worry About This Unexpected FDA Move?

Eli Lilly (NYSE: LLY) sells treatments for a wide variety of therapeutic areas, but one portfolio in particular has driven major gains in recent times. And that's the company's weight loss drugs. Lilly sells the compound tirzepatide under two different names -- Mounjaro for type 2 diabetes and Zepbound for weight loss.

Zacks.com on MSN · 1d

FDA to Reconsider Removal of Lilly's Obesity Drug From Shortage List

The FDA has agreed to review its decision to remove Eli Lilly’s LLY tirzepatide — the active ingredient used in diabetes drug Mounjaro and obesity drug Zepbound — from its shortage list. During this process,

STAT3h

Ahead of public meeting, FDA signals flexibility in evaluating smoking cessation treatments

FDA leaders said the agency was willing to consider broader endpoints in clinical trials of smoking cessation products ...

FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now

TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making compounded versions of the weight-loss medication ...

WebMD3h

FDA-Cleared Medical Devices Lack Proper Vetting, Doctors Say

Recalled heart devices often do not go through clinical testing, a new study found, highlighting growing concerns about the ...

4hon MSN

FDA identifies food safety issues at Delta food preparation facility

After the FDA discovered food safety issues at a Delta food preparation facility, the facility was shut down and multiple ...

KOAM News Now12h

FDA warns of Zero Sugar Minute Maid Lemonade recall

The Federal Drug Administration is warning consumers about a new recall involving a popular brand of lemonade.

10h

US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns

The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after ...

fingerlakes113h

FDA partners with URMC to develop digital tools for Huntington’s disease

The project, which will be conducted by URMC’s Center for Health + Technology, seeks to create objective, digital tools that can provide a clearer picture of how Huntington’s disease advances, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics